Aktuellt
SENASTE
Redeye is positive towards the company’s continuous efforts in raising awareness for the rare disease MCT8 deficiency. In a press release earlier today, Egetis Therapeutics announced the next step in its disease awareness initiatives to support earlier diagnosis of MCT8 deficiency, with the launch of a new dedicated website.
LÄS MER
